Nirsevimab and Hospitalization for RSV Bronchiolitis

• 2024

  Log in to bookmark this resource.

  Log in
• Zein Assad; Anne-Sophie Romain; Camille Aupiais; Mickaël Shum; Cécile Schrimpf; Mathie Lorrot
PMID: 38986058DOI: https://dx.doi.org/10.1056/NEJMoa2314885

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This study looks at how well nirsevimab, a monoclonal antibody, works in preventing hospitalizations for RSV bronchiolitis in infants under 12 months. Conducted across multiple centers, it compares infants hospitalized with RSV to those visiting hospitals for other reasons. Results show that nirsevimab reduces the risk of hospitalization by 83% and is also effective against severe cases needing critical care or ventilatory support. The findings suggest that nirsevimab can significantly lower the chances of serious RSV-related illness in young children.

---

Tags

Focus Area: Infectious Disease

Keywords: Antiviral Agents; Bronchiolitis; Hospitalization; Infant; Infant, Newborn; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Antibodies, Monoclonal, Humanized

Emergency Management Stage: Preparedness (Prevention / Protection)

Audience: Physicians

Format: Journal Article

Media Type: Website

Institutions: Paris Cité University; Sorbonne University; INSERM Unité

Institution Types: International Government; Academic; Academic

Language: English

Bundles: Nirsevimab Library

---

More like this

Nirsevimab and Hospitalization for RSV Bronchiolitis 2024 · Paris Cité University, Sorbonne University, INSERM Unité Chemical-Biological Terrorism and Its Impact on Children [2020] 2020 · Harvard Medical School, Boston Children's Hospital, Yale University, Children's Hospital Colorado, University of Colorado, American Academy of Pediatrics (AAP) The Assessment of Future RSV Immunizations: How to Protect All Infants? 2022 · University Medical Centre Utrecht, Paris Cité University, University of Lübeck, University of Parma, Comunidad de Madrid, Università Degli Studi Di Milano Statale, European Foundation for the Care of Newborn Infants (EFCNI), Nihon University School of Medicine, Beijing Children's Hospital, University of Thessaly, University of Southampton, University Hospital Southampton NHS Foundation Trust, Bambino Gesù Children Hospital

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---